Napp announces acceptance of Rezafungin Marketing Authorisation Application
16 Nov 2022 //
BUSINESSWIRE
Napp Pharmaceuticals Announces European Commission Approval of Invokana®
02 Jul 2020 //
BUSINESSWIRE
Napp Announces European Commission Approval of Invokana® (canagliflozin)
01 Jul 2020 //
BUSINESSWIRE
 
			 
								

 Market Place
 Market Place Sourcing Support
 Sourcing Support
